Related Experiment Videos
On the specificity of carboxypeptidase N, a comparative study
D Hendriks1, M Vingron, G Vriend
1Department of Pharmaceutical Sciences, University of Antwerp, Belgium.
Summary
Human plasma carboxypeptidase N structure was modeled using homology to bovine carboxypeptidase A. This enzyme modeling aids drug design by revealing substrate specificity differences.
Area of Science:
- Biochemistry
- Structural Biology
- Enzymology
Background:
- Human plasma carboxypeptidase N (CPA N) plays a crucial role in regulating peptide hormones.
- Understanding CPA N's structure is vital for developing targeted therapeutics.
- Bovine carboxypeptidase A (CPB A) shares structural similarities, providing a basis for homology modeling.
Purpose of the Study:
- To model the structure of the enzymatically active subunit of human plasma carboxypeptidase N.
- To investigate the active site conservation between CPA N and CPB A.
- To hypothesize and experimentally validate differences in substrate specificity between CPA N and CPB A.
Main Methods:
- Homology modeling was used to predict the 3D structure of human CPA N based on the known structure of bovine CPB A.
- Energetic analysis of binding sites was performed using atomic probe groups.
- Small synthetic peptide substrates were synthesized and tested to confirm the derived hypothesis on substrate specificity.
Main Results:
- The active site of human CPA N is highly conserved compared to bovine CPB A.
- A hypothesis explaining the differing substrate specificities of CPA N and CPB A was formulated based on binding site analysis.
- Experimental validation using synthetic peptide substrates supported the hypothesis regarding substrate specificity.
Conclusions:
- Homology modeling, even with low sequence identity, can generate high-quality models for drug design.
- The study provides insights into the structural basis for substrate specificity differences between CPA N and CPB A.
- The developed model of human CPA N can serve as a valuable tool for future drug discovery efforts targeting this enzyme.